Antibody discovered that blocks almost all known HIV variants in neutralization assays

Looking ahead, this could revolutionize the fight against HIV, potentially paving the way for long-acting therapies or even boosting vaccine development by mimicking elite neutralizer responses. Imagine a future where annual antibody infusions replace daily antiretrovirals, drastically improving quality of life and adherence for millions. But what challenges lie ahead—will clinical trials confirm these results in humans, and how might resistance evolve? Could this inspire similar breakthroughs for other mutating viruses like influenza or coronaviruses?